SoftOx Solutions AS — Share Issue/Capital Change 2024

May 10, 2024

Softox Solutions AS: New share capital

Softox Solutions AS: New share capital

Not for release, publication or distribution, in whole or in part directly or indirectly, in Australia, Canada, Japan or the United States (or any other jurisdiction in which the release, publication or distribution would be unlawful). This announcement does not constitute an offer of any of the securities described herein.

Reference is made to the stock exchange release from SoftOx Solutions AS (the "Company") 30 April 2024 regarding the final result of the Subsequent Offering and allocation of Offer shares.

The new share capital following completion of the Subsequent Offering has today been registered with the Norwegian Register of Business Enterprises.

The new share capital of the Company is NOK 10.335.392,82 divided into 516,769,641 shares, each with a par value of NOK 0.02.

For any questions or interview requests, please contact:

Geir Almås, Chair of SoftOx Solutions AS

Mail: ir@soft-ox.com

Phone: Geir Almås: (+47) 977 59 071

About SoftOx Solutions AS

SoftOx Solutions AS (SoftOx) is a Medtech and pharmaceutical company listed on Euronext Growth Oslo under 'SOFTX'. SoftOx Solutions AS was founded in 2012 and is headquartered in Oslo. The SoftOx Solutions Group includes: the holding company SoftOx Solutions AS, the Malmö subsidiary, and subsidiaries SoftOx Defense Solutions AS and SoftOx Disinfection AS. SoftOx is developing a highly effective antimicrobial solution for use in biofilm, viral and antimicrobial resistant infections. The patent-protected technology is based on extensive research and development in partnership with leading Nordic research institutes.

For more information on SoftOx, visit www.soft-ox.com